Christopher G Chalklin1, Elizabeth G Ryan Harper1, Andrew J Beamish2,3,4. 1. Cardiff and Vale University Health Board, Cardiff, UK. 2. Department of Gastrosurgical Research, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden. beamishaj@gmail.com. 3. Swansea University Medical School, Swansea University, Swansea, UK. beamishaj@gmail.com. 4. Department of GastroSurgical Research and Education, Sahlgrenska Universitetsjukhuset, Institute of Clinical Sciences, Gothenburg University, Gothenburg, 41431, UK. beamishaj@gmail.com.
Abstract
PURPOSE OF REVIEW: The prevalence of obesity is increasing in all age groups. Following its success in adults, and with limited success using conservative therapies, metabolic and bariatric surgery (MBS) is increasingly being utilized in adolescents. This review highlights the current evidence and guidelines supporting its use. RECENT FINDINGS: Safety and efficacy mirror results seen in adults. The most recent evidence, as outcomes enter the long term, suggests that comorbidity resolution, including diabetes and hypertension, can even outperform that of adults. Mental health problems persist despite good weight loss. Overall, the positive early weight and comorbidity outcomes are well sustained into the long term. There is a growing need to prevent and treat adolescent obesity. Current evidence supports the use of MBS in adolescents. Ongoing and future studies will provide 10-year outcomes and assist in the refinement of multimodal pathways incorporating MBS for the treatment of severe childhood obesity.
PURPOSE OF REVIEW: The prevalence of obesity is increasing in all age groups. Following its success in adults, and with limited success using conservative therapies, metabolic and bariatric surgery (MBS) is increasingly being utilized in adolescents. This review highlights the current evidence and guidelines supporting its use. RECENT FINDINGS: Safety and efficacy mirror results seen in adults. The most recent evidence, as outcomes enter the long term, suggests that comorbidity resolution, including diabetes and hypertension, can even outperform that of adults. Mental health problems persist despite good weight loss. Overall, the positive early weight and comorbidity outcomes are well sustained into the long term. There is a growing need to prevent and treat adolescent obesity. Current evidence supports the use of MBS in adolescents. Ongoing and future studies will provide 10-year outcomes and assist in the refinement of multimodal pathways incorporating MBS for the treatment of severe childhood obesity.
Authors: S Jay Olshansky; Douglas J Passaro; Ronald C Hershow; Jennifer Layden; Bruce A Carnes; Jacob Brody; Leonard Hayflick; Robert N Butler; David B Allison; David S Ludwig Journal: N Engl J Med Date: 2005-03-17 Impact factor: 91.245
Authors: Katherine M Flegal; Rong Wei; Cynthia L Ogden; David S Freedman; Clifford L Johnson; Lester R Curtin Journal: Am J Clin Nutr Date: 2009-09-23 Impact factor: 7.045
Authors: Aaron S Kelly; Sarah E Barlow; Goutham Rao; Thomas H Inge; Laura L Hayman; Julia Steinberger; Elaine M Urbina; Linda J Ewing; Stephen R Daniels Journal: Circulation Date: 2013-09-09 Impact factor: 29.690
Authors: Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman Journal: Surg Obes Relat Dis Date: 2018-03-23 Impact factor: 4.734
Authors: Torsten Olbers; Andrew J Beamish; Eva Gronowitz; Carl-Erik Flodmark; Jovanna Dahlgren; Gustaf Bruze; Kerstin Ekbom; Peter Friberg; Gunnar Göthberg; Kajsa Järvholm; Jan Karlsson; Staffan Mårild; Martin Neovius; Markku Peltonen; Claude Marcus Journal: Lancet Diabetes Endocrinol Date: 2017-01-06 Impact factor: 32.069